Efficacy of Glucosamine Sulphate in Skin Ageing: Results from an ex vivo Anti-Ageing Model and a Clinical Trial

被引:7
|
作者
Gueniche, Audrey [1 ]
Castiel-Higounenc, Isabelle [1 ]
机构
[1] LOreal Res & Innovat, Aulnay Sous Bois, France
关键词
Collagen; Glucosamine sulphate; Skin ageing; Skin structure; Skin physiology; HEPARAN-SULFATE; PHOTOAGED SKIN; CELL-ADHESION; IN-VIVO; COLLAGEN; AGE; TISSUE; GLYCOSAMINOGLYCANS; MODULATION; VIMENTIN;
D O I
10.1159/000450832
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background: Glucosamine sulphate (GS) is essential in the biosynthesis of glycolipids, glycoproteins, glycosaminoglycans (GAGs), hyaluronate, and proteoglycans. Connective tissues primarily contain collagen and proteoglycans and play an important role in skin ageing. Objective: The objectives were to assess ex vivo the impact of GS on skin ageing parameters and in vivo the effect of GS on the skin physiology of mature healthy volunteers after oral intake. Methods: The impact of GS on skin ageing was assessed ex vivo via different immunohistochemical assays and histology and via a clinical study using biopsies. Modulation of selected skin physiology markers was assessed by real- time quantitative PCR on skin punch biopsies obtained from 8 healthy >50-year-old women having ingested GS 250 mg once daily for 8 weeks. Results: Ex vivo, GS significantly (all p <= 0.02) increased the expression of CD44 and collagen type IV, the epidermis GAG level, and collagen type I synthesis. After 8 weeks of oral GS administration, a significantly increased expression was observed at the mRNA level for vimentin, fibromodulin, biglycan, xylosyl transferase, hyaluronan synthase, collagen types I and III, bone morphogenic protein-1, and decorin (all p <= 0.05). Conclusion: Both experiments showed that GS has a positive effect on epidermal and dermal markers associated with age. (C) 2017 S. Karger AG, Basel
引用
收藏
页码:36 / 41
页数:6
相关论文
共 39 条
  • [31] The effect of oral collagen peptide supplementation on skin moisture and the dermal collagen network: evidence from an ex vivo model and randomized, placebo-controlled clinical trials
    Asserin, Jerome
    Lati, Elian
    Shioya, Toshiaki
    Prawitt, Janne
    [J]. JOURNAL OF COSMETIC DERMATOLOGY, 2015, 14 (04) : 291 - 301
  • [32] Prediction of skin anti-aging clinical benefits of an association of ingredients from marine and maritime origins: Ex vivo evaluation using a label-free quantitative proteomic and customized data processing approach
    Hameury, Sebastien
    Borderie, Laurent
    Monneuse, Jean-Marc
    Skorski, Gilbert
    Pradines, Dominique
    [J]. JOURNAL OF COSMETIC DERMATOLOGY, 2019, 18 (01) : 355 - 370
  • [33] Cosibelimab, an anti-PD-L1 antibody, in metastatic cutaneous squamous cell carcinoma (mCSCC): Preliminary safety and efficacy results from a phase I clinical trial
    Clingan, P.
    Brungs, D.
    Ladwa, R.
    Mant, A. M.
    McGrath, M.
    Tazbirkova, A.
    Koralewski, P.
    Lugowska, I.
    Charoentum, C.
    Dechaphunkul, A.
    Sriuranpong, V.
    Oliviero, J.
    Harris, D. L.
    [J]. ANNALS OF ONCOLOGY, 2020, 31 : S736 - S736
  • [34] Long-term clinical and angiographic outcomes in patients with diabetes undergoing coronary artery bypass graft surgery: Results from the PRoject of Ex-vivo Vein graft ENgineering via Transfection IV Trial
    Koshizaka, Masaya
    Lopes, Renato D.
    Reyes, Eric M.
    Gibson, C. Michael
    Schulte, Phillip J.
    Hafley, Gail E.
    Hernandez, Adrian F.
    Green, Jennifer B.
    Kouchoukos, Nicholas T.
    Califf, Robert M.
    Ferguson, T. Bruce
    Peterson, Eric D.
    Alexander, John H.
    [J]. AMERICAN HEART JOURNAL, 2015, 169 (01) : 175 - 184
  • [35] Safety and Efficacy of RP1+Nivolumab in Patients with Non-Melanoma Skin Cancer of the Head and Neck: Results From IGNYTE Phase 1/2 Multi-Cohort Clinical Trial
    Niu, J.
    Milhem, M.
    Vanderwalde, A. M.
    Chmielowski, B.
    Beasley, G.
    Samson, A.
    Sacco, J. J.
    Bowles, T.
    Jew, T.
    He, S.
    Raza, S.
    Harrington, K.
    Middleton, M. R.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 112 (05): : E8 - E9
  • [36] Effect of young age at diagnosis on clinical outcomes and efficacy of anti-HER2 targeted therapy in patients with HER2-positive early breast cancer: Results from the APHINITY trial
    Lambertini, Matteo
    Fielding, Shona
    Loibl, Sibylle
    Janni, Wolfgang
    Clark, Emma
    Franzoi, Maria Alice
    Fumagalli, Debora
    Caballero, Carmela
    Arecco, Luca
    Salomoni, Sharon
    Ponde, Noam F.
    Poggio, Francesca
    Kim, Hee Jeong
    Villarreal-Garza, Cynthia
    Pagani, Olivia
    Paluch-Shimon, Shani
    Ballestrero, Alberto
    Del Mastro, Lucia
    Piccart, Martine
    Bines, Jose
    Partridge, Ann H.
    de Azambuja, Evandro
    [J]. CANCER RESEARCH, 2022, 82 (04)
  • [37] Efficacy and Safety of Anti-Programmed Death-Ligand 1 Monoclonal Antibody Socazolimab With Carboplatin and Etoposide for Extensive-Stage SCLC: Results From the Phase 1b Clinical Trial
    Lu, Shun
    Chen, Zhiwei
    Cui, Jiuwei
    Guo, Renhua
    Li, Ziming
    Li, Benjamin Xiaoyi
    Dai, Xiangrong
    [J]. JTO CLINICAL AND RESEARCH REPORTS, 2023, 4 (04):
  • [38] Efficacy and safety of the anti-PD-L1 monoclonal antibody Socazolimab in combination with carboplatin and etoposide for extensive-stage small cell lung cancer: Results from the phase Ib clinical trial
    Lu, S.
    Chen, Z.
    Li, Z.
    Zhou, Z.
    Yu, Y.
    Ai, X.
    Zhao, Y.
    Niu, X.
    Cui, J.
    Guo, R.
    Li, B. X.
    Dai, X.
    Li, Y.
    Wong, M. S.
    Ng, R.
    Zhao, Z.
    [J]. ANNALS OF ONCOLOGY, 2022, 33 : S99 - S99
  • [39] Interim Results of a Phase II Clinical Trial Comparing Outcomes of Recipients of Lungs Recovered from Uncontrolled Donation After Circulatory Determination of Death Donors (uDCDDs) Assessed by Ex-Vivo Lung Perfusion (EVLP) and CT Scan to Outcomes of Recipients of Lungs from Brain-Dead Donors (BDDs)
    Egan, T. M.
    Haithcock, B.
    Long, J.
    Birchard, K.
    Lobo, J.
    Stewart, P.
    Blackwell, J.
    Yuan, D.
    Thys, C.
    Karb, D.
    Miller, S.
    Hartwig, M.
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2016, 35 (04): : S372 - S372